Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

Could two of the league’s biggest brands stop or delay the Big Ten's massive impending private equity deal? Could the other ...

Omeros Corporation maintained with Strong Buy rating after securing a $2.1 billion partnership with Novo Nordisk for ...

The transplanted kidney did start to show signs of type A blood again by the third day, which led to an immune response – but ...

Thousands of people in Chicago and nationwide need a kidney transplant, and like Christine Hernandez, they have to launch ...

Tubulis has completed a Series C, securing €308m ($361m) to be directed towards advancing clinical development of its ADC ...

Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding its clinical development in IgA ...

After a decade of work, researchers are closer than ever to a key breakthrough in kidney organ transplants - being able to ...

Scientists have developed a universal kidney transplant by converting a donor kidney to blood type O, enabling compatibility with any recipient.

Certain graphics on this page may be affected by ad-blocking software. If portions of the page appear blank and an ad blocker is enabled, please disable the ad blocker and refresh the page to ensure ...